Three products of New Horizon Health (HKG:6606) have recently been listed with the Hong Kong government's Department of Health under the Medical Device Administrative Control System (MDACS), a Tuesday bourse filing said.

The products include ColoClear, a screening test for colorectal cancer; Pupu Tube, a screening product to detect hemoglobin biomarkers associated with colorectal cancer; and UU Tube, a screening product for H. pylori.

Medical devices can be listed with the Department of Health using MDACS if they conform to the accepted standards of safety and performance.

Trading in the company's shares, which was suspended March 28, remains suspended.